Oarsman Capital’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-950
| Closed | -$42.6K | – | 377 |
|
|
2024
Q4 | $42.6K | Sell |
950
-483
| -34% | -$27.1K | 0.01% | 474 |
|
|
2024
Q3 | $90.1K | Buy |
+1,433
| New | +$83.6K | 0.02% | 362 |
|
|
2024
Q2 | – | Sell |
-15,839
| Closed | -$1.26M | – | 237 |
|
|
2024
Q1 | $1.26M | Sell |
15,839
-186
| -1% | -$14.2K | 0.3% | 76 |
|
|
2023
Q4 | $1.27M | Buy |
16,025
+756
| +5% | +$53.8K | 0.34% | 68 |
|
|
2023
Q3 | $1.07M | Sell |
15,269
-431
| -3% | -$30.5K | 0.45% | 61 |
|
|
2023
Q2 | $1.09M | Sell |
15,700
-917
| -6% | -$65.2K | 0.48% | 55 |
|
|
2023
Q1 | $1.23M | Sell |
16,617
-1,943
| -10% | -$163K | 0.58% | 46 |
|
|
2022
Q4 | $1.73M | Sell |
18,560
-283
| -2% | -$27.3K | 0.88% | 30 |
|
|
2022
Q3 | $1.8M | Sell |
18,843
-14,927
| -44% | -$1.48M | 0.96% | 26 |
|
|
2022
Q2 | $3.13M | Buy |
33,770
+312
| +0.9% | +$30.4K | 1.55% | 15 |
|
|
2022
Q1 | $3.39M | Sell |
33,458
-11,904
| -26% | -$1.25M | 1.32% | 17 |
|
|
2021
Q4 | $4.68M | Sell |
45,362
-353
| -0.8% | -$32.6K | 1.85% | 10 |
|
|
2021
Q3 | $3.88M | Sell |
45,715
-3,889
| -8% | -$326K | 1.57% | 10 |
|
|
2021
Q2 | $4.14M | Sell |
49,604
-2,831
| -5% | -$232K | 1.64% | 10 |
|
|
2021
Q1 | $3.94M | Sell |
52,435
-4,718
| -8% | -$344K | 1.71% | 11 |
|
|
2020
Q4 | $3.9M | Buy |
57,153
+2,243
| +4% | +$146K | 1.52% | 14 |
|
|
2020
Q3 | $3.21M | Sell |
54,910
-1,128
| -2% | -$70.2K | 1.45% | 18 |
|
|
2020
Q2 | $3.64M | Buy |
56,038
+13,097
| +30% | +$825K | 1.8% | 11 |
|
|
2020
Q1 | $2.55M | Sell |
42,941
-6,804
| -14% | -$454K | 2.35% | 10 |
|
|
2019
Q4 | $3.7M | Buy |
49,745
+756
| +2% | +$53.1K | 1.69% | 12 |
|
|
2019
Q3 | $3.09M | Sell |
48,989
-9,849
| -17% | -$584K | 1.47% | 16 |
|
|
2019
Q2 | $3.21M | Buy |
58,838
+11,932
| +25% | +$643K | 1.45% | 15 |
|
|
2019
Q1 | $2.53M | Sell |
46,906
-13,900
| -23% | -$858K | 1.2% | 24 |
|
|
2018
Q4 | $3.98M | Sell |
60,806
-9,854
| -14% | -$736K | 2.04% | 9 |
|
|
2018
Q3 | $5.56M | Buy |
70,660
+21,275
| +43% | +$1.52M | 2.24% | 5 |
|
|
2018
Q2 | $3.18M | Buy |
49,385
+10,096
| +26% | +$665K | 1.44% | 19 |
|
|
2018
Q1 | $2.44M | Sell |
39,289
-1,133
| -3% | -$81.3K | 1.11% | 29 |
|
|
2017
Q4 | $2.93M | Sell |
40,422
-1,287
| -3% | -$93.6K | 1.26% | 22 |
|
|
2017
Q3 | $3.39M | Buy |
41,709
+2,316
| +6% | +$183K | 1.43% | 19 |
|
|
2017
Q2 | $3.17M | Buy |
39,393
+2,582
| +7% | +$204K | 1.45% | 18 |
|
|
2017
Q1 | $2.89M | Buy |
36,811
+14,161
| +63% | +$1.13M | 1.35% | 21 |
|
|
2016
Q4 | $1.79M | Buy |
+22,650
| New | +$1.83M | 1.15% | 27 |
|
Other funds holding CVS
Oarsman Capital's CVS Position: Q1 2025 in Review
Oarsman Capital sold out of CVS Health (CVS) in Q1 2025, closing a stake of 950 shares — an estimated $42.6K sold.
Oarsman Capital first reported a position in CVS in Q4 2016 and held it in 32 quarters. The position peaked at $5.56M in Q3 2018. 1,752 funds tracked by Wall St. Rank hold CVS as of Q1 2025.
- Oarsman Capital reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
- Oarsman Capital sold 950 CVS Health shares in Q1 2025, an estimated $42.6K.
- Oarsman Capital first reported a position in CVS Health in Q4 2016 and held it in 32 quarters.
- Oarsman Capital's CVS Health position peaked at $5.56M in Q3 2018.
- 1,752 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.
Based on Oarsman Capital's 13F filing for Q1 2025, filed 14 May 2025.